Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Addressing ART Safety and Tolerability in Transgender Individuals

Source: State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care
Listen as 2 experts discuss approaches to ART safety and tolerability in transgender individuals, including clinically relevant drug interactions and additional considerations such as gender-affirming care.
Jill Blumenthal, MD, MAS
Jennifer Cocohoba Headshot
Jennifer Cocohoba, PharmD
Released: December 7, 2022

In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including:

  • Strategies on how to approach different ARV-related toxicities
  • Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovascular disease), such as gender-affirming care and nonmedication risk factors (eg, smoking, life stressors)
  • Clinically relevant drug–drug interactions related to HIV and gender-affirming care
  • Methods to reduce barriers to ART adherence

Information on this Educational Activity

Faculty

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jill Blumenthal, MD, MAS: researcher: Gilead Sciences.
Jennifer Cocohoba, PharmD

Professor
Department of Clinical Pharmacy
University of California, San Francisco
Pharmacist
Women's HIV Program
University of California San Francisco Medical Center
San Francisco, California

Jennifer Cocohoba, PharmD: researcher: Genentech, Janssen, ViiV Healthcare, Walgreens.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings